Scientist II, Peptide Drug Discovery

The Mission: Engineering the Undruggable

Parabilis Medicines is pioneering a new class of Helicon peptides to reach intracellular targets that traditional drugs simply can't touch. As a Scientist II, you will join a clinical-stage team in Cambridge to scale an AI-driven discovery platform. You won't just be running experiments; you will be architecting the high-throughput systems that identify the next generation of cancer therapies.

The Tech: AI-Assisted Lab Automation

This role is designed for a 'builder' who blends deep chemical biology expertise with modern development practices. Your primary focus will be:

• Workflow Scripting: Developing reusable, lightweight code to automate assay execution and QC, reducing manual overhead.
• Robotic Integration: Designing experimental assays with laboratory automation and AI-driven agents in mind to ensure seamless data integration.
• AI Tooling: Leveraging LLMs and AI-assisted coding to rapidly iterate on tools for experiment tracking and quantitative analysis.

Growth and Impact

Joining Parabilis means working at the intersection of wet-lab science and cutting-edge digital automation. With significant Series F backing and a lead asset already in clinical trials, you will have the resources to innovate and the autonomy to implement AI-driven solutions. This is an ideal environment for a scientist who wants to redefine how drug discovery is performed through the lens of modern tech and vibe coding principles.